# US 2017/0283870 A1 · Methods for detection of nucleotide modification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283870 A1
- Document ID: US20170283870A1
- Status: Published application
- Kind: A1
- Application number: 15/508,520
- Filed: 2015-09-07
- Published: 2017-10-05
- Earliest claimed: 2014-09-05
- Assignees: Cambridge Epigenetix Limited
- Applicants: Cambridge Epigenetix Ltd
- Inventors: Tobias William Barr OST; Neil Matthew BELL; Maria Chiara Erminia CATENAZZI
- Web page: https://patentgrep.com/patent/US20170283870A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6858: Allele-specific amplification
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This invention relates to improved methods and kits for identification of 5-formylcytosine (5fC) to be distinguished from cytosine (C) in a sample nucleotide sequence. Methods comprise reducing a first portion of polynucleotides which comprise the sample nucleotide sequence; treating the reduced first portion and a second portion of polynucleotides with bisulfite; sequencing the polynucleotides in the first and second portions of the population to produce first and second nucleotide sequences respectively and; identifying the residues in the first and second nucleotide sequences which correspond to a cytosine residue in the sample nucleotide sequence. These methods may be useful, for example in the analysis of genomic DNA and/or of RNA.

## Claims

### Claim 1

A method of identifying a 5-formylcytosine residue in a sample nucleotide sequence comprising;
(i) providing a population of single stranded polynucleotides which comprise the sample nucleotide sequence,
(ii) reducing a first portion of said population by adding an alkaline borohydride solution,
(iii) treating the reduced first portion of said population and a second portion of said population with bisulfite,
(iv) sequencing the polynucleotides in the first and second portions of the population following steps ii) and iii) to produce first and second nucleotide sequences, respectively and;
(v) identifying the residues in the first and second nucleotide sequences which correspond to a 5-formylcytosine residue in the sample nucleotide sequence.

### Claim 2 (depends on 1)

The method according to claim 1 wherein identification of cytosine at a position in the first nucleotide sequence and uracil at the same position in the second nucleotide sequence is indicative that the cytosine residue in the sample nucleotide sequence is 5-formylcytosine (5fC).

### Claim 3 (depends on 1)

The method according to claim 1 comprising;
(i) providing a population of single stranded polynucleotides which comprise the sample nucleotide sequence,
(ii) reducing a first portion of said population by adding an alkaline borohydride solution,
(iii) oxidising a second portion of said population,
(iv) treating the reduced first portion, oxidised second portion and a third portion of said population with bisulfite,
(v) sequencing the polynucleotides in the first, second and third portions of the population following steps ii), iii) and iv) to produce first, second and third nucleotide sequences, respectively and;
(vi) identifying the residues in the first, second and third nucleotide sequences which correspond to a cytosine residue in the sample nucleotide sequence.

### Claim 4 (depends on 3)

The method according to claim 3 wherein identification of cytosine at a position in the first, second and third nucleotide sequences is indicative that the cytosine residue in the sample nucleotide sequence is 5-methylcytosine.

### Claim 5 (depends on 1)

The method according to claim 1 wherein the first portion of said population is reduced using a solution of alkaline NaBH4.

### Claim 6 (depends on 1)

The method according to claim 1 wherein identification of uracil at a position in both the first and the second nucleotide sequence is indicative that the cytosine residue in the sample nucleotide sequence is unmodified cytosine.

### Claim 7 (depends on 1)

The method according to claim 1 comprising;
providing a fourth portion of the population of polynucleotides comprising sample nucleotide sequence; and,
sequencing the polynucleotides in the fourth portion to produce the sample nucleotide sequence.

### Claim 8 (depends on 1)

The method according to claim 1 wherein the polynucleotides are genomic DNA.

### Claim 9 (depends on 1)

The method according to claim 1 wherein the single stranded polynucleotides are in alkaline solution prior to borohydride treatment.

### Claim 10 (depends on 1)

The method according to claim 1 wherein the population of polynucleotides or one or more of the first, second, third and fourth portions of the population are immobilised.

### Claim 11 (depends on 1)

The method according to claim 1 wherein one or more of the first, second, third and fourth portions of the population are amplified before sequencing.

### Claim 12 (depends on 11)

The method according to claim 11 wherein one or more of the first, second, third portions of the population are amplified following treatment with bisulfite.

### Claim 13 (depends on 1)

The method according to claim 1 wherein the final borohydride concentration in step (ii) is 10 to 200 mM.

### Claim 14 (depends on 1)

The kit for use in a method of identifying a 5-formylcytosine residue according to claims 1 comprising;
(i) an alkaline borohydride solution; and,
(ii) a bisulfite reagent.

### Claim 15 (depends on 14)

The kit according to claim 14 further comprising an alkaline solution.

### Claim 16 (depends on 14)

The kit according to claim 14 wherein the alkaline borohydride solution is sodium borohydride at pH greater than 10.0.

### Claim 17 (depends on 14)

The kit according to claim 14 wherein the alkaline borohydride solution contains hydroxide.

### Claim 18 (depends on 17)

The kit according to claim 17 wherein the hydroxide is present at a concentration of greater than 1 Moles/L.

### Claim 19 (depends on 17)

The kit according to claim 17 wherein the hydroxide is present at a concentration of greater than 5 Moles/L.
